MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 Lifeward, a pioneering company at the forefront of medical technology, has announced the launch of the ReWalk 7 personal exoskeleton in the U.S. market. This state-of-the-art seventh-generation device is designed for individuals with spinal cord injuries, enabling greater mobility and independence. The launch represents a significant milestone in Lifeward s commitment to enhancing the quality of life for those affected by severe mobility impairments.
The ReWalk 7 exoskeleton builds upon the success of its predecessors, leveraging advanced robotics and cutting-edge engineering to create a device that mimics natural walking patterns. Equipped with intuitive motion sensing and user-friendly controls, the ReWalk 7 empowers users to stand, walk, and even climb stairs with unprecedented ease. This development not only restores a sense of mobility but also fosters emotional and psychological well-being among users.
As the latest evolution in personal exoskeleton technology, ReWalk 7 reflects our dedication to innovation and the importance of empowering individuals with spinal cord injuries, said Name, CEO of Lifeward. We re committed to pushing the boundaries of rehabilitation technology to create solutions that make a genuine difference in people s lives.
The launch was met with excitement across the medical community as the ReWalk 7 promises improved accessibility for those requiring assistive mobility devices. It represents a bedtime narrative of hope, showcasing Lifeward’s determination to bridge the gap between technology and the needs of individuals with disabilities.
In addition to the ReWalk 7, Lifeward has also unveiled the latest addition to its AlterG MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 Lifeward, a pioneering company at the forefront of medical technology, has announced the launch of the ReWalk 7 personal exoskeleton in the U.S. market. This state-of-the-art seventh-generation device is designed for individuals with spinal cord injuries, enabling greater mobility and independence. The launch represents a significant milestone in Lifeward s commitment to enhancing the quality of life for those affected by severe mobility impairments. "https://csimarket.com/stocks/at_glance.php?code=LFWD">LFWD">product line: the AlterG NEO. Designed with an updated user-friendly interface and advanced Anti-Gravity technology, the AlterG NEO addresses the varied needs of both physical rehabilitation and athletic training. This innovative device provides precise and consistent unweighting, enabling users to engage in impactful physical activities without the typical barriers posed by gravity.
The AlterG NEO is poised to revolutionize rehabilitation sessions by allowing patients to undertake weight-bearing exercises in a controlled and supportive environment. This benefit not only accelerates recovery time but also enhances the effectiveness of physical therapy, making it a preferred choice for clinics, hospitals, and training facilities.
“With the AlterG NEO, we are setting a new standard in rehabilitation technology, allowing for a safer and more effective path to recovery and athletic performance,” stated Name, Chief Technology Officer at Lifeward. “We prioritize combining user comfort with technology that inspires confidence and encourages progress.”
Together, the ReWalk 7 and AlterG NEO highlight Lifeward’s unwavering commitment to improving the lives of individuals through innovative medical solutions. By incorporating user feedback and advancing scientific research, Lifeward is dedicated to creating opportunities for people to achieve their rehabilitation goals, recover their independence, and gain a renewed sense of normalcy.
The launch of these groundbreaking products signifies a noteworthy advancement in the landscape of rehabilitation technology. Lifeward continues to pave the way in the industry, proving that through innovation and compassion, people with spinal cord injuries and mobility challenges can rediscover the joy of movement.

Comments